ibogaine has been researched along with dimethylphenylpiperazinium iodide in 1 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (dimethylphenylpiperazinium iodide) | Trials (dimethylphenylpiperazinium iodide) | Recent Studies (post-2010) (dimethylphenylpiperazinium iodide) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 766 | 1 | 46 |
| Protein | Taxonomy | ibogaine (IC50) | dimethylphenylpiperazinium iodide (IC50) |
|---|---|---|---|
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 2.62 | |
| DNA dC->dU-editing enzyme APOBEC-3A isoform a | Homo sapiens (human) | 1.93 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liauw, PE; Mah, SJ; Nagel, JE; Schneider, AS; Tang, Y | 1 |
1 other study(ies) available for ibogaine and dimethylphenylpiperazinium iodide
| Article | Year |
|---|---|
Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release.
Topics: Animals; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Hallucinogens; Ibogaine; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Tetrodotoxin | 1998 |